Compounder Empower receives FDA warning letter over GLP-1s
The FDA has issued a warning letter to compounder Empower Pharmacy over its GLP-1 weight loss treatments. It’s the third warning the Houston-based company has received in less than two years. In the
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.